PH

Paul R. Hinton

PB Pdl Biopharma: 6 patents #2 of 40Top 5%
AV Abb Vie: 5 patents #334 of 1,257Top 30%
PP Progenics Pharmaceuticals: 3 patents #17 of 53Top 35%
FB Facet Biotech: 3 patents #8 of 31Top 30%
AB AbbVie: 2 patents #669 of 1,308Top 55%
Abbott: 2 patents #2,462 of 5,431Top 50%
EL Eli Lilly: 1 patents #1,742 of 2,858Top 65%
AR Arius Research: 1 patents #11 of 15Top 75%
GI Genetics Institute: 1 patents #199 of 327Top 65%
CU Columbia University: 1 patents #1,151 of 2,492Top 50%
📍 Sunnyvale, CA: #1,123 of 14,302 inventorsTop 8%
🗺 California: #25,620 of 386,348 inventorsTop 7%
Overall (All Time): #194,053 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
11344621 Interleukin-13 binding proteins Chengbin Wu, Richard W. Dixon, Jonathan Belk, Hua Ying, Maria A. Argiriadi +4 more 2022-05-31
10150814 Fc variants with improved complement activation Veronica Juan 2018-12-11
10086076 Interleukin-13 binding proteins Chengbin Wu, Richard W. Dixon, Jonathan Belk, Hua Ying, Maria A. Argiriadi +4 more 2018-10-02
9592293 Interleukin-13 binding proteins Chengbin Wu, Richard W. Dixon, Jonathan Belk, Maria A. Argiriadi, Hua Ying +4 more 2017-03-14
8629257 IL-12/p40 binding proteins Susan E. Lacy, Emma Fung, Jonathan Belk, Richard W. Dixon, Michael Roguska +1 more 2014-01-14
8624007 Alteration of Fc-fusion protein serum half-lives by mutagenesis Naoya Tsurushita 2014-01-07
8604177 Interleukin-13 binding proteins Chengbin Wu, Richard W. Dixon, Jonathan Belk, Maria A. Argiriadi, Hua Ying +4 more 2013-12-10
7915388 Interleukin-13 binding proteins Chengbin Wu, Richard W. Dixon, Jonathan Belk, Maria A. Argiriadi, Hua Ying +4 more 2011-03-29
7851600 Anti-CCR5 antibody William Olson, Paul J. Maddon, Naoya Tsurushita, Maximiliano Vasquez 2010-12-14
7732570 Alteration of Fc-fusion protein serum half-lives by mutagenesis Naoya Tsurushita 2010-06-08
7700739 IL-12/p40 binding proteins Susan E. Lacy, Emma Fung, Jonathan Belk, Richard W. Dixon, Michael Roguska +1 more 2010-04-20
7666419 Anti-CCR5 antibody William Olson, Paul J. Maddon, Naoya Tsurushita, Maximillano Vasquez 2010-02-23
7442777 Cytotoxicity mediation of cells evidencing surface expression of CD63 David S. F. Young, Helen P. Findlay, Susan E. Hahn, Luis DA CRUZ, Daad Sayegh +2 more 2008-10-28
7365168 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Naoya Tsurushita, J. Yun Tso, Maximiliano Vasquez 2008-04-29
7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Naoya Tsurushita, J. Yun Tso, Maximiliano Vasquez 2008-04-22
7320790 Humanized antibodies Maximiliano Vasquez 2008-01-22
7223393 Amphiregulin antibodies and their use to treat cancer and psoriasis Nicholas F. Landolfi, Naoya Tsurushita, Shankar Kumar 2007-05-29
7217798 Alteration of Fc-fusion protein serum half-lives by mutagenesis Naoya Tsurushita 2007-05-15
7217797 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Naoya Tsurushita, J. Yun Tso, Maximiliano Vasquez 2007-05-15
7122185 Anti-CCR5 antibody William Olson, Paul J. Maddon, Naoya Tsurushita, Maximillano Vasquez 2006-10-17
7034121 Antibodies against CTLA4 Beatriz Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary S. Gray +3 more 2006-04-25
6218149 Antibodies having modified carbohydrate content and methods of preparation and use Sherie L. Morrison, Vernon T. Oi 2001-04-17